Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD) GlobeNewswire August 04, 2025 – Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 – WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, […]

MediWound to Report Second Quarter 2025 Financial Results

MediWound to Report Second Quarter 2025 Financial Results GlobeNewswire August 04, 2025 MediWound to Report Second Quarter 2025 Financial Results Conference call and webcast scheduled for Thursday, August 14 at 8:30 a.m. Eastern Time YAVNE, Israel, August 4, 2025 — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today

Digi Power X Reports 122% Month-Over-Month Increase in Cash and Crypto Position with No Long-Term Debt and Reports July 2025 Production Results

Digi Power X Reports 122% Month-Over-Month Increase in Cash and Crypto Position with No Long-Term Debt and Reports July 2025 Production Results GlobeNewswire August 04, 2025 This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May

Mobiquity Technologies Launches CMOne – A Fully Agentic AI Marketing Platform for Unified Brand Engagement

Mobiquity Technologies Launches CMOne – A Fully Agentic AI Marketing Platform for Unified Brand Engagement GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Mobiquity Technologies, Inc. (OTCQB: MOBQ), a leading provider of next-generation data intelligence and advertising technology solutions, today announced the launch of CMOne, a first-of-its-kind fully agentic AI marketing

Early Bird Registration Now Open for The Inaugural OpenSSL Conference 2025

Early Bird registration is now available for the inauguralOpenSSL Conference, scheduled for October 7-9, 2025, in Prague. The event will bring together leading voices in cryptography, secure systems, and open-source infrastructure. Early registrants can save up to $240 per ticket. https://mma.prnewswire.com/media/2743438/OpenSSL_Conf.jpg Registration Information Registration packages are designed to reflect the diversity of the OpenSSL Communities,

Securities Lawsuit Alert: PepGen Inc. (PEPG) – Contact Levi & Korsinsky Before August 8, 2025

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=159526&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Neogen Corporation (NEOG) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 16, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=159527&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Teva Pharmaceutical Industries Limited Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – TEVA

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teva Pharmaceutical Industries Limited ("Teva Pharmaceutical Industries Limited") (NYSE:TEVA) concerning possible violations of federal securities laws. On July 31, 2025, Teva published a press release reporting the Company’s second quarter 2025 financial

Recover Investment Losses: Levi & Korsinsky Files Class Action Against Sarepta Therapeutics, Inc. (SRPT)

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=159537&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Supernova Asbestos Surveys Provides Critical Asbestos Testing and Survey Services in London to Ensure Safety and Compliance

London, London – Asbestos contamination remains a serious threat to public health, particularly in older buildings across London. Supernova Asbestos Surveys provides expert asbestos containment services, including asbestos management surveys, asbestos refurbishment surveys, asbestos testing, and asbestos removal. In addition to asbestos containment services, Supernova Asbestos Surveys London offers fire risk assessment solutions to identify

Scroll to Top